Pfizer had been submitting data on its vaccine on a “rolling basis” to the U.K., meaning regulators there were able to review the data in real time.
Source: Business - cnbc.com
Pfizer had been submitting data on its vaccine on a “rolling basis” to the U.K., meaning regulators there were able to review the data in real time.
Source: Business - cnbc.com